Eli & Co Lilly, 10% Owner at UNITED THERAPEUTICS Corp (UTHR), sold 860,546 shares at $54.99 ($46.6M) on 2011-07-06, disclosed to the SEC on 2011-07-06.
Open-market sale of $46.6M UTHR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.15 | 811,443 | $43.9M | 94.2% |
| 2 | $54.99 | 49,103 | $2.7M | 5.8% |
| Total | $54.20 avg | 860,546 | $46.6M | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |